University of Pittsburgh: Schizophrenia trials
The registry lists 21 Schizophrenia studies with University of Pittsburgh as lead sponsor. 2 are open to participants now and 5 have results posted.
Phase 1 1Phase 2 4Phase 4 5No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Feasibility and Acceptability of Mobile Mental Health App for SZ and SZANot yet recruitingNCT06474325Not applicable
- Prucalopride for Cognitive Functioning in SchizophreniaNot yet recruitingNCT06474286Not applicable
- tDCS and Cognitive Training Intervention for Chronic Smokers With SchizophreniaTerminatedNCT03588728Not applicableResults posted
- Integrated Care (IC) Models for Patient-Centered OutcomesCompletedNCT03451630Not applicableResults posted
- Person-Centered Versus Measurement-Based Care in Mental HealthCompletedNCT02507349Not applicableResults posted
- Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid SupplementationCompletedNCT00167310Phase 2Results posted
- Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 StudyCompletedNCT00129441Phase 2Results posted
- Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric DisordersCompletedNCT07043803Not applicable
- Cue-based Intervention in Prospective Memory and Medication Adherence.Active, not recruitingNCT06474195Not applicable
- Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)Active, not recruitingNCT04143126Not applicable
- Neural Biomarkers of Clozapine ResponseCompletedNCT03076346
- Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course SchizophreniaCompletedNCT02011750Phase 4
- Valacyclovir Augmentation for Cognitive and Functional Remediation in SchizophreniaCompletedNCT01794897Phase 4
- Adapted Cognitive/Affective Remediation for Cannabis Misuse in SchizophreniaCompletedNCT01292577Phase 1/2
- The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With SchizophreniaCompletedNCT00222833Phase 4
- Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes MellitusCompletedNCT00222807
- A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With SchizophreniaCompletedNCT00222794Phase 4
- Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With PravastatinCompletedNCT00177580Phase 4
- L-carnosine for SchizophreniaCompletedNCT00177177Not applicable
- Reducing the Weight of Overweight Schizophrenia PatientsCompletedNCT00158366Not applicable
- Treatment of Schizophrenia Through Internet-Based PsychoeducationCompletedNCT00051233Phase 2